https://www.epmmagazine.com/topics/antibodies/index.rss en-gb © 2020 Rapid Life Sciences Ltd, a Rapid News Group Company. All Rights Reserved. Tue, 13 Apr 2021 09:41:06 -0000 FairJourney Biologics (FJB) and IONTAS are collaborating with immunology company argenx on a project to advance the discovery of next generation antibodies. https://www.epmmagazine.com/news/fairjourney-biologics-enters-antibody-discovery-partnership-/ https://www.epmmagazine.com/news/fairjourney-biologics-enters-antibody-discovery-partnership-/ Tue, 13 Apr 2021 09:41:06 -0000 Collaboration Biotech company Orgenesis has launched an initiative to help mitigate the spread of viruses such as Covid-19, through the discovery and validation of neutralising human antibodies. https://www.epmmagazine.com/news/biotech-launches-programme-to-help-mitigate-spread-of-viruse/ https://www.epmmagazine.com/news/biotech-launches-programme-to-help-mitigate-spread-of-viruse/ Thu, 11 Jun 2020 09:40:00 -0000 Viral spread Health secretary Matt Hancock will appeal to the biotech industry to help the UK find an antibody test that works in a bid to tackle COVID-19. https://www.epmmagazine.com/news/uk-to-ask-biotech-industry-to/ https://www.epmmagazine.com/news/uk-to-ask-biotech-industry-to/ Wed, 08 Apr 2020 15:24:20 -0000 Testing A North East recombinant antibody manufacturer has developed custom protein purification systems to help increase its production throughput. https://www.epmmagazine.com/news/north-east-manufacturer/ https://www.epmmagazine.com/news/north-east-manufacturer/ Mon, 04 Mar 2019 09:20:00 -0000 Antibodies ProBioGen (service and technology provider for complex therapeutic glycoproteins) and Pionyr Immunotherapeutics have initiated a second immune-oncology contract development and manufacturing project. https://www.epmmagazine.com/news/probiogen-pionyr-initiate-second-immune-oncology-project/ https://www.epmmagazine.com/news/probiogen-pionyr-initiate-second-immune-oncology-project/ Thu, 19 Jul 2018 09:00:00 -0000 Handshake agreement Catalent Pharma Solutions, global provider of advanced delivery technologies and development solutions, has announced it will adopt Berkeley Lights’ Beacon optofluidic platform to accelerate its cell line development workflow https://www.epmmagazine.com/technology/catalent-to-adopt-beacon-optofluidic-platform/ https://www.epmmagazine.com/technology/catalent-to-adopt-beacon-optofluidic-platform/ Thu, 12 Jul 2018 11:33:55 -0000 collaboration IONTAS, a company focused on the discovery and optimisation of fully human antibodies, has signed a collaboration agreement with Korean-based LG Chem to identify therapeutic oncology leads. https://www.epmmagazine.com/news/collaboration-agreement-signed-for-therapeutic-oncology-leads/ https://www.epmmagazine.com/news/collaboration-agreement-signed-for-therapeutic-oncology-leads/ Wed, 06 Jun 2018 14:37:48 -0000 Collaborate Biotechnology company focused on the discovery and optimisation of fully human antibodies, IONTAS, has been awarded a major grant to support ongoing research into its novel antibody platform, KnotBody. https://www.epmmagazine.com/news/biotech-receives-grant-in-support-of-ongoing-research/ https://www.epmmagazine.com/news/biotech-receives-grant-in-support-of-ongoing-research/ Thu, 31 May 2018 10:49:47 -0000 Funding Company focused on the discovery and optimisation of fully human antibodies, IONTAS, and a private biopharmaceutical company, aTen Therapeutics, have announced a collaboration for the discovery of therapeutic oncology leads. https://www.epmmagazine.com/news/collaboration-announced-for-therapeutic-oncology-leads/ https://www.epmmagazine.com/news/collaboration-announced-for-therapeutic-oncology-leads/ Thu, 03 May 2018 10:04:26 -0000 Research collaboration A collaboration between IONTAS, a company focused on the discovery and optimisation of fully human antibodies, and IGEM Therapeutics, an immunologist-oncology company, for the identification of novel IgE antibodies for cancer targets. https://www.epmmagazine.com/news/collaboration-formed-for-development-of-novel-ige-antibodies/ https://www.epmmagazine.com/news/collaboration-formed-for-development-of-novel-ige-antibodies/ Wed, 04 Apr 2018 14:07:23 -0000 Collaborate German service and technology provider, ProBioGen, and immune-oncology company, Surface Oncology, have signed a second antibody development project for the development and manufacture of another antibody for potential use in clinical trials. https://www.epmmagazine.com/news/probiogen-surface-oncology-sign-second-agreement/ https://www.epmmagazine.com/news/probiogen-surface-oncology-sign-second-agreement/ Tue, 13 Mar 2018 13:24:28 -0000 Sign agreement Biotechnology company, ADC Biotechnology, has announced that it is developing a new ‘downstream bioconjugation’ method that will enable conjugation and antibody purification to be performed concurrently. https://www.epmmagazine.com/news/new-bioconjugation-method-will-save-on-manufacturing-time-sa/ https://www.epmmagazine.com/news/new-bioconjugation-method-will-save-on-manufacturing-time-sa/ Tue, 13 Feb 2018 12:12:27 -0000 The clock is ticking Two recently published clinical studies have demonstrated a new approach using antibodies to target specific chemicals in the brain may help significantly reduce the incidence and severity of migraines. https://www.epmmagazine.com/news/companies-race-to-get-ahead-in-new-approach-to-tackle-migrai/ https://www.epmmagazine.com/news/companies-race-to-get-ahead-in-new-approach-to-tackle-migrai/ Thu, 30 Nov 2017 11:01:21 -0000 Migraine Regeneron Pharmaceuticals has announced plans to discontinue further clinical development of its antibody, suptavumab, for respiratory syncytial virus, as it has not met the primary endpoint of preventing infections in infants in the Phase III study https://www.epmmagazine.com/news/regeneron-discontinues-clinical-development-of-antibody-for-/ https://www.epmmagazine.com/news/regeneron-discontinues-clinical-development-of-antibody-for-/ Wed, 16 Aug 2017 13:13:28 -0000 Stop sign Felicity Thomas BBI Solutions have launched more than 20 new antibodies in their product portfolio as a result of demands in the market place. This extended portfolio now includes cardiac, cancer, inflammation and fertility markers. https://www.epmmagazine.com/news/bbi-solutions-expand-antibody-portfolio/ https://www.epmmagazine.com/news/bbi-solutions-expand-antibody-portfolio/ Thu, 13 Apr 2017 10:50:55 -0000 Antibody Cambridge Research Biochemicals (CRB), specialist in the synthesis of custom peptides and antibody production has announced the release of its new Discovery Antibodies catalogue. https://www.epmmagazine.com/news/cambridge-research-biochemicals-announces-new/ https://www.epmmagazine.com/news/cambridge-research-biochemicals-announces-new/ Tue, 21 Feb 2017 09:50:00 -0000 Peptides Alastair Smith Alastair Smith, Avacta Life Sciences, outlines the company’s work developing engineered alternatives to antibodies https://www.epmmagazine.com/opinion/in-profile/ https://www.epmmagazine.com/opinion/in-profile/ Mon, 28 Sep 2015 15:28:17 -0000 Alastair Smith 1.jpg Kymab, a Cambridge-based antibodies-to-medicines company, is featured in the top ten of The Sunday Times Tech Track ‘Ones to Watch’ 2015 list https://www.epmmagazine.com/news/kymab-biotech-company-that-is-one-to-watch/ https://www.epmmagazine.com/news/kymab-biotech-company-that-is-one-to-watch/ Mon, 07 Sep 2015 08:33:00 -0000 antibodies.jpg A website has been launched by Avacta Life Sciences in order to showcase its new affimer technology. https://www.epmmagazine.com/technology/avacta-launches-affirmer-website/ https://www.epmmagazine.com/technology/avacta-launches-affirmer-website/ Wed, 05 Aug 2015 13:11:00 -0000 Avacta Catalent has signed an exclusive licencing agreement to access Excelimmune's antibody combination therapy technology platform, which has the potential to pave the way for more consistent, cost-effective production of antibody combinations. https://www.epmmagazine.com/news/catalent-granted-licence-to-antibody-combination-platform/ https://www.epmmagazine.com/news/catalent-granted-licence-to-antibody-combination-platform/ Tue, 07 Jul 2015 14:59:00 -0000 Antibody drug conjugate The search engine is a powerful clone, antibody and protein products search and buying tool, which gives researchers easy access to millions of products https://www.epmmagazine.com/news/source-bioscience-launches-intelligent-genomecube-search-eng/ https://www.epmmagazine.com/news/source-bioscience-launches-intelligent-genomecube-search-eng/ Wed, 10 Sep 2014 10:32:42 -0000 Nick Ash bio_s.jpg The agreement will give customers faster, easier access to Abcam’s high-quality antibodies. https://www.epmmagazine.com/abcam-and-cell-marque-sign-global-strategic-marketing-agreem/ https://www.epmmagazine.com/abcam-and-cell-marque-sign-global-strategic-marketing-agreem/ Thu, 04 Sep 2014 12:59:00 -0000 signing.jpg The range is for use in key imaging applications including immunofluorescence, flow cytometry, and fluorescent western blotting. https://www.epmmagazine.com/technology/abcam-introduces-exclusive-range-of-highly-validated-antibod/ https://www.epmmagazine.com/technology/abcam-introduces-exclusive-range-of-highly-validated-antibod/ Wed, 03 Sep 2014 10:36:00 -0000 abcam.jpg Lu Rahman A study has been published outlining the simultaneous measurement of protein charge and diffusion interaction parameter (kD) https://www.epmmagazine.com/news/study-showcases-automated-dual-measurement-capabilities-of-m/ https://www.epmmagazine.com/news/study-showcases-automated-dual-measurement-capabilities-of-m/ Wed, 11 Jun 2014 13:45:00 -0000 protein.jpg Comparing the antibodies of sharks, which are very old from an evolutionary perspective, with those of humans, a team of researchers at the Technische Universitaet Muenchen and the Helmholtz Zentrum Muenchen discovered stabilising mechanisms... https://www.epmmagazine.com/news/shark-antibodies-inspire-optimisation-of-human-antibodies/ https://www.epmmagazine.com/news/shark-antibodies-inspire-optimisation-of-human-antibodies/ Thu, 15 May 2014 14:51:00 -0000 TUM